Press "Enter" to skip to content

Glenmark gets final nod from USFDA for angina treatment drug

The product is a generic version of Gilead Sciences Inc’s Ranexa extended-release tablets in the same strengths.

Original source: https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-final-nod-from-usfda-for-angina-treatment-drug/70151174?utm_source=RSS&utm_medium=ETRSS

Also Read:   Rival drugmakers launch joint trial of medicines for covid-19